859MO Sacituzumab govitecan (SG) in patients (pts) with relapsed/refractory (R/R) advanced head and neck squamous cell carcinoma (HNSCC): Results from the phase II TROPiCS-03 basket trial
| Autor: | Michel, L., Jimeno, A., Sukari, A., Beck, T., Chiu, J.W.Y., Ahern, E.S., Hilton, J., A. Hollebecque, Zanetta, S., Patel, J., Mekan, S., Wu, T., Dumbrava, E.E. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S558-S558 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|